Breast Cancer Stage IV Clinical Trials in Seville
2 recruitingSeville, Spain
Showing 1–2 of 2 trials
Recruiting
Phase 2
Trastuzumab Deruxtecan in First-Line HER2-Positive Metastatic Breast Cancer With Proactive Toxicity Management
Breast Cancer Stage IV
SOLTI Breast Cancer Research Group300 enrolled27 locationsNCT07371585
Recruiting
Phase 2
HR+/HER2- Advanced or Metastatic Breast Cancer Patients Treated With Sacituzumab Govitecan
Breast Cancer Stage IV
SOLTI Breast Cancer Research Group50 enrolled10 locationsNCT06236269